Brief: Biocartis Updates on Five Idylla Studies
Nov 5 (Reuters) - Biocartis Group NV BCART.BR :
* REG-PRESS RELEASE BIOCARTIS NV: FIVE IDYLLA™ STUDIES TO BE
PUBLISHED AT ‘ASSOCIATION FOR MOLECULAR PATHOLOGY' ANNUAL
MEETING (US)
* RESPECTIVE IDYLLA STUDIES SHOWED A STRONG PERFORMANCE OF
IDYLLA™
ASSAYS (RUO) COMPARED TO OTHER METHODS INCLUDING IHC AND NGS
Source text for Eikon: ID:nGNE6ZM1L1
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies